Vimarsana
Biggest News Aggregation in the World

Topspin Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topspin Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topspin Fund Today - Breaking & Trending Today

Neuvotion Raises Additional $1.25M in Funding - Vimarsana News

Neuvotion Raises Additional $1.25M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

SetPoint Medical raises $80M for nerve stimulation tech that treats autoimmune disease - Vimarsana News

SetPoint Medical raises $80M for nerve stimulation tech that treats autoimmune disease

Autoimmune disease treatment developer SetPoint Medical announced today that it raised $80 million in a preferred stock financing.

SetPoint Medical Raises $80M in Funding - Vimarsana News

SetPoint Medical Raises $80M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Neuvotion Secures over $1M in Seed Funding to Commercialize Neurostimulation Technology - Vimarsana News

Neuvotion Secures over $1M in Seed Funding to Commercialize Neurostimulation Technology

/PRNewswire/ -- Neuvotion, Inc., an early-stage medical device company developing neurostimulation products for the rehabilitation and physical therapy...

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform - Vimarsana News

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform January 27, 2021 09:00 ET | Source: SetPoint Medical SetPoint Medical Valencia, California VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA). The company is developing its platform for the treatment of chronic, inflammation-mediated autoimmune diseases and is i...